S.B. No. 449
 
 
 
 
AN ACT
  relating to the penalty group classification of certain controlled
  substances.
         BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
         SECTION 1.  Section 481.102, Health and Safety Code, is
  amended to read as follows:
         Sec. 481.102.  PENALTY GROUP 1. Penalty Group 1 consists of:
               (1)  the following opiates, including their isomers,
  esters, ethers, salts, and salts of isomers, esters, and ethers,
  unless specifically excepted, if the existence of these isomers,
  esters, ethers, and salts is possible within the specific chemical
  designation:
                     Alfentanil;
                     Allylprodine;
                     Alphacetylmethadol;
                     Benzethidine;
                     Betaprodine;
                     Clonitazene;
                     Diampromide;
                     Diethylthiambutene;
                     Difenoxin not listed in Penalty Group 3 or 4;
                     Dimenoxadol;
                     Dimethylthiambutene;
                     Dioxaphetyl butyrate;
                     Dipipanone;
                     Ethylmethylthiambutene;
                     Etonitazene;
                     Etoxeridine;
                     Furethidine;
                     Hydroxypethidine;
                     Ketobemidone;
                     Levophenacylmorphan;
                     Meprodine;
                     Methadol;
                     Moramide;
                     Morpheridine;
                     Noracymethadol;
                     Norlevorphanol;
                     Normethadone;
                     Norpipanone;
                     Phenadoxone;
                     Phenampromide;
                     Phenomorphan;
                     Phenoperidine;
                     Piritramide;
                     Proheptazine;
                     Properidine;
                     Propiram;
                     Sufentanil;
                     Tilidine; and
                     Trimeperidine;
               (2)  the following opium derivatives, their salts,
  isomers, and salts of isomers, unless specifically excepted, if the
  existence of these salts, isomers, and salts of isomers is possible
  within the specific chemical designation:
                     Acetorphine;
                     Acetyldihydrocodeine;
                     Benzylmorphine;
                     Codeine methylbromide;
                     Codeine-N-Oxide;
                     Cyprenorphine;
                     Desomorphine;
                     Dihydromorphine;
                     Drotebanol;
                     Etorphine, except hydrochloride salt;
                     Heroin;
                     Hydromorphinol;
                     Methyldesorphine;
                     Methyldihydromorphine;
                     Monoacetylmorphine;
                     Morphine methylbromide;
                     Morphine methylsulfonate;
                     Morphine-N-Oxide;
                     Myrophine;
                     Nicocodeine;
                     Nicomorphine;
                     Normorphine;
                     Pholcodine; and
                     Thebacon;
               (3)  the following substances, however produced,
  except those narcotic drugs listed in another group:
                     (A)  Opium and opiate not listed in Penalty Group
  3 or 4, and a salt, compound, derivative, or preparation of opium or
  opiate, other than thebaine derived butorphanol, nalmefene and its
  salts, naloxone and its salts, and naltrexone and its salts, but
  including:
                           Codeine not listed in Penalty Group 3 or 4;
                           Dihydroetorphine;
                           Ethylmorphine not listed in Penalty Group 3
  or 4;
                           Granulated opium;
                           Hydrocodone not listed in Penalty Group 3;
                           Hydromorphone;
                           Metopon;
                           Morphine not listed in Penalty Group 3;
                           Opium extracts;
                           Opium fluid extracts;
                           Oripavine;
                           Oxycodone;
                           Oxymorphone;
                           Powdered opium;
                           Raw opium;
                           Thebaine; and
                           Tincture of opium;
                     (B)  a salt, compound, isomer, derivative, or
  preparation of a substance that is chemically equivalent or
  identical to a substance described by Paragraph (A), other than the
  isoquinoline alkaloids of opium;
                     (C)  Opium poppy and poppy straw;
                     (D)  Cocaine, including:
                           (i)  its salts, its optical, position, and
  geometric isomers, and the salts of those isomers;
                           (ii)  coca leaves and a salt, compound,
  derivative, or preparation of coca leaves;
                           (iii)  a salt, compound, derivative, or
  preparation of a salt, compound, or derivative that is chemically
  equivalent or identical to a substance described by Subparagraph
  (i) or (ii), other than decocainized coca leaves or extractions of
  coca leaves that do not contain cocaine or ecgonine; and
                     (E)  concentrate of poppy straw, meaning the crude
  extract of poppy straw in liquid, solid, or powder form that
  contains the phenanthrine alkaloids of the opium poppy;
               (4)  the following opiates, including their isomers,
  esters, ethers, salts, and salts of isomers, if the existence of
  these isomers, esters, ethers, and salts is possible within the
  specific chemical designation:
                     Acetyl-alpha-methylfentanyl (N-[1-(1-methyl-2-
  phenethyl)-4-piperidinyl]-N-phenylacetamide);
                     Alpha-methylthiofentanyl (N-[1-methyl-2-(2-
  thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide);
                     Alphaprodine;
                     Anileridine;
                     Beta-hydroxyfentanyl (N-[1-(2-hydroxy-2-
  phenethyl)-4-piperidinyl] -N-phenylpropanamide);
                     Beta-hydroxy-3-methylfentanyl;
                     Bezitramide;
                     Carfentanil;
                     Dihydrocodeine not listed in Penalty Group 3 or 4;
                     Diphenoxylate not listed in Penalty Group 3 or 4;
                     Fentanyl or alpha-methylfentanyl, or any other
  derivative of Fentanyl;
                     Isomethadone;
                     Levomethorphan;
                     Levorphanol;
                     Metazocine;
                     Methadone;
                     Methadone-Intermediate, 4-cyano-2-dimethylamino-
  4, 4-diphenyl butane;
                     3-methylfentanyl(N-[3-methyl-1-(2-phenylethyl)-
  4-piperidyl]-N-phenylpropanamide);
                     3-methylthiofentanyl(N-[3-methyl-1-(2-thienyl)
  ethyl-4-piperidinyl]-N-phenylpropanamide);
                     Moramide-Intermediate, 2-methyl-3-morpholino-1,
  1-diphenyl-propane-carboxylic acid;
                     Para-fluorofentanyl(N-(4-fluorophenyl)-N-1-(2-
  phenylethyl)-4-piperidinylpropanamide);
                     PEPAP (1-(2-phenethyl)-4-phenyl-4-
  acetoxypiperidine);
                     Pethidine (Meperidine);
                     Pethidine-Intermediate-A, 4-cyano-1-methyl-4-
  phenylpiperidine;
                     Pethidine-Intermediate-B, ethyl-4-
  phenylpiperidine-4 carboxylate;
                     Pethidine-Intermediate-C, 1-methyl-4-
  phenylpiperidine-4-carboxylic acid;
                     Phenazocine;
                     Piminodine;
                     Racemethorphan;
                     Racemorphan;
                     Remifentanil; and
                     Thiofentanyl(N-phenyl-N-[1-(2-thienyl)ethyl-4-pi
  peridinyl]-propanamide);
               (5)  Flunitrazepam (trade or other name: Rohypnol);
               (6)  Methamphetamine, including its salts, optical
  isomers, and salts of optical isomers;
               (7)  Phenylacetone and methylamine, if possessed
  together with intent to manufacture methamphetamine;
               (8)  Phencyclidine, including its salts;
               (9)  Gamma hydroxybutyric acid (some trade or other
  names: gamma hydroxybutyrate, GHB), including its salts; and
               (10)  Ketamine.
         SECTION 2.  Subsection (a), Section 481.103, Health and
  Safety Code, is amended to read as follows:
         (a)  Penalty Group 2 consists of:
               (1)  any quantity of the following hallucinogenic
  substances, their salts, isomers, and salts of isomers, unless
  specifically excepted, if the existence of these salts, isomers,
  and salts of isomers is possible within the specific chemical
  designation:
                     alpha-ethyltryptamine;
                     alpha-methyltryptamine;
                     4-bromo-2, 5-dimethoxyamphetamine (some trade or
  other names: 4-bromo-2, 5-dimethoxy-alpha-methylphenethylamine;
  4-bromo-2, 5-DMA);
                     4-bromo-2, 5-dimethoxyphenethylamine;
                     Bufotenine (some trade and other names: 3-(beta-
  Dimethylaminoethyl)-5-hydroxyindole; 3-(2-dimethylaminoethyl)- 5-
  indolol; N, N-dimethylserotonin; 5-hydroxy-N, N-
  dimethyltryptamine; mappine);
                     Diethyltryptamine (some trade and other names: N,
  N-Diethyltryptamine, DET);
                     2, 5-dimethoxyamphetamine (some trade or other
  names: 2, 5-dimethoxy-alpha-methylphenethylamine; 2, 5-DMA);
                     2, 5-dimethoxy-4-ethylamphetamine (trade or other
  name: DOET);
                     2, 5-dimethoxy-4-(n)-propylthiophenethylamine
  (trade or other name: 2C-T-7);
                     Dimethyltryptamine ( trade or other name: DMT);
                     Dronabinol (synthetic) in sesame oil and
  encapsulated in a soft gelatin capsule in a U.S. Food and Drug
  Administration approved drug product (some trade or other names for
  Dronabinol: (a6aR-trans)-6a,7,8,10a-tetrahydro- 6,6, 9-
  trimethyl-3-pentyl-6H- dibenzo [b,d]pyran-1-ol or (-)-delta-9-
  (trans)- tetrahydrocannabinol);
                     Ethylamine Analog of Phencyclidine (some trade or
  other names: N-ethyl-1-phenylcyclohexylamine, (1-
  phenylcyclohexyl) ethylamine, N-(1-phenylcyclohexyl) ethylamine,
  cyclohexamine, PCE);
                     Ibogaine (some trade or other names: 7-Ethyl-6,
  6, beta 7, 8, 9, 10, 12, 13-octahydro-2-methoxy-6, 9-methano-5H-
  pyrido [1', 2':1, 2] azepino [5, 4-b] indole; tabernanthe iboga.);
                     Mescaline;
                     5-methoxy-N, N-diisopropyltryptamine;
                     5-methoxy-3, 4-methylenedioxy amphetamine;
                     4-methoxyamphetamine (some trade or other names:
  4-methoxy-alpha-methylphenethylamine; paramethoxyamphetamine;
  PMA);
                     1-methyl- 4-phenyl-4-propionoxypiperidine (MPPP,
  PPMP);
                     4-methyl-2, 5-dimethoxyamphetamine (some trade
  and other names: 4-methyl-2, 5-dimethoxy-alpha-
  methylphenethylamine; "DOM"; "STP");
                     3,4-methylenedioxy methamphetamine (MDMA, MDM);
                     3,4-methylenedioxy amphetamine;
                     3,4-methylenedioxy N-ethylamphetamine (Also
  known as N-ethyl MDA);
                     Nabilone (Another name for nabilone: (+)-trans-
  3-(1,1-dimethylheptyl)- 6,6a, 7,8,10,10a-hexahydro-1-hydroxy- 6,
  6-dimethyl-9H-dibenzo[b,d] pyran-9-one;
                     N-benzylpiperazine (some trade or other names:
  BZP; 1-benzylpiperazine);
                     N-ethyl-3-piperidyl benzilate;
                     N-hydroxy-3,4-methylenedioxyamphetamine (Also
  known as N-hydroxy MDA);
                     4-methylaminorex;
                     N-methyl-3-piperidyl benzilate;
                     Parahexyl (some trade or other names: 3-Hexyl-1-
  hydroxy-7, 8, 9, 10-tetrahydro-6, 6, 9-trimethyl-6H-dibenzo [b, d]
  pyran; Synhexyl);
                     1-Phenylcyclohexylamine;
                     1-Piperidinocyclohexanecarbonitrile (PCC);
                     Psilocin;
                     Psilocybin;
                     Pyrrolidine Analog of Phencyclidine (some trade
  or other names: 1-(1-phenylcyclohexyl)-pyrrolidine, PCPy, PHP);
                     Tetrahydrocannabinols, other than marihuana, and
  synthetic equivalents of the substances contained in the plant, or
  in the resinous extractives of Cannabis, or synthetic substances,
  derivatives, and their isomers with similar chemical structure and
  pharmacological activity such as:
                           delta-1 cis or trans tetrahydrocannabinol,
  and their optical isomers;
                           delta-6 cis or trans tetrahydrocannabinol,
  and their optical isomers;
                           delta-3, 4 cis or trans
  tetrahydrocannabinol, and its optical isomers;
                           compounds of these structures, regardless of
  numerical designation of atomic positions, since nomenclature of
  these substances is not internationally standardized;
                     Thiophene Analog of Phencyclidine (some trade or
  other names: 1-[1-(2-thienyl) cyclohexyl] piperidine; 2-Thienyl
  Analog of Phencyclidine; TPCP, TCP);
                     1-pyrrolidine (some trade or other name: TCPy);
                     1-(3-trifluoromethylphenyl)piperazine (trade or
  other name: TFMPP); and
                     3,4,5-trimethoxy amphetamine;
               (2)  Phenylacetone (some trade or other names:
  Phenyl-2-propanone; P2P, Benzymethyl ketone, methyl benzyl
  ketone); and
               (3)  unless specifically excepted or unless listed in
  another Penalty Group, a material, compound, mixture, or
  preparation that contains any quantity of the following substances
  having a potential for abuse associated with a depressant or
  stimulant effect on the central nervous system:
                     Aminorex (some trade or other names: aminoxaphen;
  2-amino-5-phenyl-2-oxazoline; 4,5-dihydro-5-
  phenyl-2-oxazolamine);
                     Amphetamine, its salts, optical isomers, and
  salts of optical isomers;
                     Cathinone (some trade or other names: 2-amino-1-
  phenyl-1-propanone, alpha-aminopropiophenone, 2-
  aminopropiophenone);
                     Etorphine Hydrochloride;
                     Fenethylline and its salts;
                     Lisdexamfetamine, including its salts, isomers,
  and salts of isomers;
                     Mecloqualone and its salts;
                     Methaqualone and its salts;
                     Methcathinone (some trade or other names: 2-
  methylamino-propiophenone; alpha-(methylamino)propriophenone;
  2-(methylamino)-1-phenylpropan-1-one; alpha-N-
  methylaminopropriophenone; monomethylpropion; ephedrone, N-
  methylcathinone; methylcathinone; AL-464; AL-422; AL-463; and UR
  1431);
                     N-Ethylamphetamine, its salts, optical isomers,
  and salts of optical isomers; and
                     N,N-dimethylamphetamine (some trade or other
  names: N,N,alpha-trimethylbenzeneethaneamine;
  N,N,alpha-trimethylphenethylamine), its salts, optical isomers,
  and salts of optical isomers.
         SECTION 3.  Subsection (a), Section 481.104, Health and
  Safety Code, is amended to read as follows:
         (a)  Penalty Group 3 consists of:
               (1)  a material, compound, mixture, or preparation that
  contains any quantity of the following substances having a
  potential for abuse associated with a stimulant effect on the
  central nervous system:
                     Methylphenidate and its salts; and
                     Phenmetrazine and its salts;
               (2)  a material, compound, mixture, or preparation that
  contains any quantity of the following substances having a
  potential for abuse associated with a depressant effect on the
  central nervous system:
                     a substance that contains any quantity of a
  derivative of barbituric acid, or any salt of a derivative of
  barbituric acid not otherwise described by this subsection;
                     a compound, mixture, or preparation containing
  amobarbital, secobarbital, pentobarbital, or any salt of any of
  these, and one or more active medicinal ingredients that are not
  listed in any penalty group;
                     a suppository dosage form containing amobarbital,
  secobarbital, pentobarbital, or any salt of any of these drugs, and
  approved by the United States Food and Drug Administration for
  marketing only as a suppository;
                     Alprazolam;
                     Amobarbital;
                     Bromazepam;
                     Camazepam;
                     Chlordiazepoxide;
                     Chlorhexadol;
                     Clobazam;
                     Clonazepam;
                     Clorazepate;
                     Clotiazepam;
                     Cloxazolam;
                     Delorazepam;
                     Diazepam;
                     Estazolam;
                     Ethyl loflazepate;
                     Fludiazepam;
                     Flurazepam;
                     Glutethimide;
                     Halazepam;
                     Haloxzolam;
                     Ketazolam;
                     Loprazolam;
                     Lorazepam;
                     Lormetazepam;
                     Lysergic acid, including its salts, isomers, and
  salts of isomers;
                     Lysergic acid amide, including its salts,
  isomers, and salts of isomers;
                     Mebutamate;
                     Medazepam;
                     Methyprylon;
                     Midazolam;
                     Nimetazepam;
                     Nitrazepam;
                     Nordiazepam;
                     Oxazepam;
                     Oxazolam;
                     Pentazocine, its salts, derivatives, or compounds
  or mixtures thereof;
                     Pentobarbital;
                     Pinazepam;
                     Prazepam;
                     Quazepam;
                     Secobarbital;
                     Sulfondiethylmethane;
                     Sulfonethylmethane;
                     Sulfonmethane;
                     Temazepam;
                     Tetrazepam;
                     Tiletamine and zolazepam in combination, and its
  salts. (some trade or other names for a tiletamine-zolazepam
  combination product: Telazol, for tiletamine: 2-(ethylamino)-
  2-(2-thienyl)-cyclohexanone, and for zolazepam: 4-(2-
  fluorophenyl)-6, 8-dihydro-1,3,8,-trimethylpyrazolo-[3,4-
  e](1,4)-d diazepin-7(1H)-one, flupyrazapon);
                     Triazolam;
                     Zaleplon; [and]
                     Zolpidem; and
                     Zopiclone;
               (3)  Nalorphine;
               (4)  a material, compound, mixture, or preparation
  containing limited quantities of the following narcotic drugs, or
  any of their salts:
                     not more than 1.8 grams of codeine, or any of its
  salts, per 100 milliliters or not more than 90 milligrams per dosage
  unit, with an equal or greater quantity of an isoquinoline alkaloid
  of opium;
                     not more than 1.8 grams of codeine, or any of its
  salts, per 100 milliliters or not more than 90 milligrams per dosage
  unit, with one or more active, nonnarcotic ingredients in
  recognized therapeutic amounts;
                     not more than 300 milligrams of dihydrocodeinone
  (hydrocodone), or any of its salts, per 100 milliliters or not more
  than 15 milligrams per dosage unit, with a fourfold or greater
  quantity of an isoquinoline alkaloid of opium;
                     not more than 300 milligrams of dihydrocodeinone
  (hydrocodone), or any of its salts, per 100 milliliters or not more
  than 15 milligrams per dosage unit, with one or more active,
  nonnarcotic ingredients in recognized therapeutic amounts;
                     not more than 1.8 grams of dihydrocodeine, or any
  of its salts, per 100 milliliters or not more than 90 milligrams per
  dosage unit, with one or more active, nonnarcotic ingredients in
  recognized therapeutic amounts;
                     not more than 300 milligrams of ethylmorphine, or
  any of its salts, per 100 milliliters or not more than 15 milligrams
  per dosage unit, with one or more active, nonnarcotic ingredients
  in recognized therapeutic amounts;
                     not more than 500 milligrams of opium per 100
  milliliters or per 100 grams, or not more than 25 milligrams per
  dosage unit, with one or more active, nonnarcotic ingredients in
  recognized therapeutic amounts;
                     not more than 50 milligrams of morphine, or any of
  its salts, per 100 milliliters or per 100 grams with one or more
  active, nonnarcotic ingredients in recognized therapeutic amounts;
  and
                     not more than 1 milligram of difenoxin and not
  less than 25 micrograms of atropine sulfate per dosage unit;
               (5)  a material, compound, mixture, or preparation that
  contains any quantity of the following substances:
                     Barbital;
                     Chloral betaine;
                     Chloral hydrate;
                     Ethchlorvynol;
                     Ethinamate;
                     Meprobamate;
                     Methohexital;
                     Methylphenobarbital (Mephobarbital);
                     Paraldehyde;
                     Petrichloral; and
                     Phenobarbital;
               (6)  Peyote, unless unharvested and growing in its
  natural state, meaning all parts of the plant classified
  botanically as Lophophora, whether growing or not, the seeds of the
  plant, an extract from a part of the plant, and every compound,
  manufacture, salt, derivative, mixture, or preparation of the
  plant, its seeds, or extracts;
               (7)  unless listed in another penalty group, a
  material, compound, mixture, or preparation that contains any
  quantity of the following substances having a stimulant effect on
  the central nervous system, including the substance's salts,
  optical, position, or geometric isomers, and salts of the
  substance's isomers, if the existence of the salts, isomers, and
  salts of isomers is possible within the specific chemical
  designation:
                     Benzphetamine;
                     Cathine [(+)-norpseudoephedrine];
                     Chlorphentermine;
                     Clortermine;
                     Diethylpropion;
                     Fencamfamin;
                     Fenfluramine;
                     Fenproporex;
                     Mazindol;
                     Mefenorex;
                     Modafinil;
                     Pemoline (including organometallic complexes and
  their chelates);
                     Phendimetrazine;
                     Phentermine;
                     Pipradrol;
                     Sibutramine; and
                     SPA [(-)-1-dimethylamino-1,2-diphenylethane];
               (8)  unless specifically excepted or unless listed in
  another penalty group, a material, compound, mixture, or
  preparation that contains any quantity of the following substance,
  including its salts:
                     Dextropropoxyphene (Alpha-(+)-4-dimethylamino-
  1,2-diphenyl-3-methyl-2-propionoxybutane); and
               (9)  an anabolic steroid, including any drug or
  hormonal substance, or any substance that is chemically or
  pharmacologically related to testosterone, other than an estrogen,
  progestin, dehydroepiandrosterone, or corticosteroid, and promotes
  muscle growth, including the following drugs and substances and any
  salt, ester, or ether of the following drugs and substances:
                     Androstanediol;
                     Androstanedione;
                     Androstenediol;
                     Androstenedione;
                     Bolasterone;
                     Boldenone;
                     Calusterone;
                     [Chlorotestosterone (4-chlortestosterone);]
                     Clostebol;
                     Dehydrochlormethyltestosterone;
                     Delta-1-dihydrotestosterone;
                     Dihydrotestosterone (4-dihydrotestosterone);
                     Drostanolone;
                     Ethylestrenol;
                     Fluoxymesterone;
                     Formebulone;
                     Furazabol;
                     13beta-ethyl-17beta-hydroxygon-4-en-3-one;
                     4-hydroxytestosterone;
                     4-hydroxy-19-nortestosterone;
                     Mestanolone;
                     Mesterolone;
                     Methandienone;
                     [Methandranone;]
                     Methandriol;
                     [Methandrostenolone;]
                     Methenolone;
                     17alpha-methyl-3beta, 17 beta-dihydroxy-5alpha-
  androstane;
                     17alpha-methyl-3alpha, 17 beta-dihydroxy-5alpha-
  androstane;
                     17alpha-methyl-3beta, 17beta-dihydroxyandrost-4-
  ene;
                     17alpha-methyl-4-hydroxynandrolone;
                     Methyldienolone;
                     Methyltestosterone;
                     Methyltrienolone;
                     17alpha-methyl-delta-1-dihydrotestosterone;
                     Mibolerone;
                     Nandrolone;
                     Norandrostenediol;
                     Norandrostenedione;
                     Norbolethone;
                     Norclostebol;
                     Norethandrolone;
                     Normethandrolone;
                     Oxandrolone;
                     Oxymesterone;
                     Oxymetholone;
                     [Stanolone;]
                     Stanozolol;
                     Stenbolone;
                     Testolactone;
                     Testosterone;
                     Tetrahydrogestrinone; and
                     Trenbolone.
         SECTION 4.  The change in law made by this Act applies only
  to an offense committed on or after the effective date of this Act.
  An offense committed before the effective date of this Act is
  covered by the law in effect when the offense was committed, and the
  former law is continued in effect for that purpose. For purposes of
  this section, an offense was committed before the effective date of
  this Act if any element of the offense was committed before that
  date.
         SECTION 5.  This Act takes effect September 1, 2009.
 
 
 
 
 
  ______________________________ ______________________________
     President of the Senate Speaker of the House     
 
         I hereby certify that S.B. No. 449 passed the Senate on
  May 7, 2009, by the following vote:  Yeas 31, Nays 0.
 
 
  ______________________________
  Secretary of the Senate    
 
         I hereby certify that S.B. No. 449 passed the House on
  May 27, 2009, by the following vote:  Yeas 148, Nays 0, one
  present not voting.
 
 
  ______________________________
  Chief Clerk of the House   
 
 
 
  Approved:
 
  ______________________________ 
              Date
 
 
  ______________________________ 
            Governor